Armbruster Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Sell
2,670
-2,022
-43% -$237K 0.05% 108
2026
Q1
$564K Buy
4,692
+400
+9% +$46.2K 0.09% 83
2025
Q4
$452K Hold
4,292
0.08% 94
2025
Q3
$360K Sell
4,292
-106
-2% -$8.73K 0.06% 104
2025
Q2
$348K Buy
4,398
+106
+2% +$8.43K 0.06% 105
2025
Q1
$385K Sell
4,292
-121
-3% -$11.3K 0.08% 98
2024
Q4
$439K Hold
4,413
0.09% 91
2024
Q3
$501K Sell
4,413
-417
-9% -$49.5K 0.1% 87
2024
Q2
$598K Buy
4,830
+8
+0.2% +$1.03K 0.12% 67
2024
Q1
$636K Sell
4,822
-85
-2% -$10.5K 0.14% 61
2023
Q4
$535K Hold
4,907
0.12% 65
2023
Q3
$505K Sell
4,907
-200
-4% -$21.6K 0.13% 65
2023
Q2
$589K Hold
5,107
0.15% 56
2023
Q1
$543K Hold
5,107
0.14% 58
2022
Q4
$567K Hold
5,107
0.15% 57
2022
Q3
$440K Sell
5,107
-25
-0.5% -$2.23K 0.13% 70
2022
Q2
$468K Sell
5,132
-23
-0.4% -$2.04K 0.13% 68
2022
Q1
$423K Sell
5,155
-200
-4% -$15.8K 0.1% 87
2021
Q4
$410K Sell
5,355
-15
-0.3% -$1.2K 0.09% 93
2021
Q3
$403K Hold
5,370
0.12% 64
2021
Q2
$418K Sell
5,370
-258
-5% -$19.2K 0.12% 65
2021
Q1
$414K Hold
5,628
0.12% 62
2020
Q4
$439K Buy
5,628
+314
+6% +$24K 0.15% 56
2020
Q3
$421K Sell
5,314
-363
-6% -$28.4K 0.16% 50
2020
Q2
$419K Buy
5,677
+352
+7% +$26.5K 0.17% 49
2020
Q1
$391K Hold
5,325
0.18% 50
2019
Q4
$462K Hold
5,325
0.18% 47
2019
Q3
$428K Hold
5,325
0.18% 46
2019
Q2
$426K Hold
5,325
0.18% 44
2019
Q1
$423K Sell
5,325
-534
-9% -$39.9K 0.18% 47
2018
Q4
$427K Sell
5,859
-151
-3% -$10.7K 0.21% 44
2018
Q3
$407K Buy
6,010
+1,157
+24% +$73.7K 0.18% 48
2018
Q2
$281K Sell
4,853
-182
-4% -$10.3K 0.13% 56
2018
Q1
$262K Sell
5,035
-314
-6% -$17K 0.12% 57
2017
Q4
$287K Sell
5,349
-75
-1% -$4.16K 0.13% 50
2017
Q3
$331K Sell
5,424
-229
-4% -$13.9K 0.17% 45
2017
Q2
$346K Buy
5,653
+189
+3% +$11.5K 0.19% 45
2017
Q1
$331K Hold
5,464
0.18% 45
2016
Q4
$307K Sell
5,464
-221
-4% -$12.9K 0.18% 47
2016
Q3
$339K Sell
5,685
-302
-5% -$17.7K 0.21% 44
2016
Q2
$329K Sell
5,987
-302
-5% -$16.1K 0.21% 48
2016
Q1
$318K Sell
6,289
-466
-7% -$22.8K 0.22% 48
2015
Q4
$340K Buy
+6,755
New +$341K 0.3% 44

Other funds holding MRK

Armbruster Capital Management's MRK Position: Q2 2026 in Review

Armbruster Capital Management reduced its Merck (MRK) stake by 43% in Q2 2026, selling an estimated $237K and leaving 2,670 shares worth $343K. The position accounts for 0.05% of the portfolio, ranked #108.

Armbruster Capital Management first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $636K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Armbruster Capital Management held 2,670 shares of Merck worth $343K as of Q2 2026.
  • Armbruster Capital Management sold 2,022 Merck shares in Q2 2026, an estimated $237K.
  • Merck made up 0.05% of Armbruster Capital Management's portfolio in Q2 2026, its #108 holding.
  • Armbruster Capital Management first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Armbruster Capital Management's Merck position peaked at $636K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.